{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:26:59Z","timestamp":1785806819658,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.10.097","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T07:45:23Z","timestamp":1352360723000},"page":"1447-1452","source":"Crossref","is-referenced-by-count":26,"title":["U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005\u20132007"],"prefix":"10.1016","volume":"31","author":[{"given":"Soju","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Jane","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (RR-3)","key":"10.1016\/j.vaccine.2012.10.097_bib0005","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.10.097_bib0010","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010","volume":"60","author":"Centers for Disease Control Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.10.097_bib0015","unstructured":"Food and Drug Administration (FDA). Complete list of vaccines licensed for immunization and distribution in the US, Product information, http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM093833; 2012 [accessed 22.10.12]."},{"issue":"May (6)","key":"10.1016\/j.vaccine.2012.10.097_bib0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The Vaccine Adverse Event Reporting System (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.097_bib0025","unstructured":"Food and Drug Administration (FDA). Postmarketing safety reporting requirements for drug and biologic products, http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm299833.htm; 2012 [accessed 22.10.12]."},{"key":"10.1016\/j.vaccine.2012.10.097_bib0030","unstructured":"The Brighton Collaboration. Case definitions. https:\/\/brightoncollaboration.org\/public\/what-we-do\/standards\/case-definitions.html; 2012 [accessed 22.10.12]."},{"issue":"October (7)","key":"10.1016\/j.vaccine.2012.10.097_bib0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/aje\/kwh269","article-title":"Myopericarditis following smallpox vaccination","volume":"160","author":"Arness","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.10.097_bib0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archpedi.1997.02170400041007","article-title":"Syncope after immunization","volume":"151","author":"Braun","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.10.097_bib0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) \u2013 United States, 1991-2001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.10.097_bib0050","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.inf.0000234067.84848.e1","article-title":"Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case\u2013control study","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.10.097_bib0055","series-title":"Institute of Medicine. Vaccine Safety Committee: adverse events associated with childhood vaccines: evidence bearing on causality","year":"1994"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.10.097_bib0060","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) \u2013 United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"August (7)","key":"10.1016\/j.vaccine.2012.10.097_bib0065","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.10.097_bib0070","series-title":"Institute of Medicine. Committee to review adverse effects of vaccines. Board on Population Health and Public Health Practice. Adverse effects of vaccines: evidence and causality","year":"2012"},{"issue":"11","key":"10.1016\/j.vaccine.2012.10.097_bib0075","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4065\/78.11.1431-a","article-title":"Acute myocarditis associated with tetanus vaccination","volume":"78","author":"Dilber","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.10.097_bib0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/adc.61.4.403","article-title":"Myocarditis after triple immunisation","volume":"61","author":"Amsel","year":"1986","journal-title":"Arch Dis Child"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.10.097_bib0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1378\/chest.120.2.671","article-title":"Acute myopericarditis after diphtheria, tetanus, and polio vaccination","volume":"120","author":"Boccara","year":"2001","journal-title":"Chest"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2012.10.097_bib0090","first-page":"280","article-title":"Myocardial complications of immunisations","volume":"10","author":"Helle","year":"1978","journal-title":"Ann Clin Res"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.10.097_bib0095","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1177\/021849230601400627","article-title":"Acute fulminant myocarditis after diphtheria, polio, and tetanus vaccination","volume":"14","author":"Wu","year":"2006","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.10.097_bib0100","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2105\/AJPH.87.12.2045","article-title":"The risk of Guillain\u2013Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States","volume":"87","author":"Tuttle","year":"1997","journal-title":"Am J Public Health"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2012.10.097_bib0105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2012.10.097_bib0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"May 17","key":"10.1016\/j.vaccine.2012.10.097_bib0115","first-page":"457","article-title":"Syncope after vaccination \u2013 United States, January 2005\u2013July 2007","volume":"57","author":"Centers for Disease Control Prevention (CDC)","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2012.10.097_bib0120","first-page":"1","article-title":"General recommendations on immunization \u2013 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Centers for Disease Control Prevention (CDC)","year":"2011","journal-title":"MMWR Recomm Rep"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.10.097_bib0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/jaut.1996.0091","article-title":"Vaccine-induced autoimmunity","volume":"9","author":"Cohen","year":"1996","journal-title":"J Autoimmun"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2012.10.097_bib0130","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.vaccine.2010.11.051","article-title":"Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990\u20132008","volume":"29","author":"Woo","year":"2011","journal-title":"Vaccine"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2012.10.097_bib0135","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1016\/j.vaccine.2007.02.063","article-title":"The development of standardized case definitions and guidelines for adverse events following immunization","volume":"25","author":"Kohl","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.10.097_bib0140","unstructured":"Food and Drug Administration (FDA). Guidance for industry: good pharmacovigilance practices and pharmacoepidemiologic assessment. http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM126834.pdf; 2012 [accessed 22.10.12]."},{"issue":"September (34)","key":"10.1016\/j.vaccine.2012.10.097_bib0145","first-page":"786","article-title":"Suspension of rotavirus vaccine after reports of intussusception \u2013 United States, 1999","volume":"53","author":"Centers for Disease Control Prevention (CDC)","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12015708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T15:57:04Z","timestamp":1540137424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12015708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X12015708"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}